Pharmaceutical
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Cosmetic Raw Material
OEM & ODM
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
DL-Carnitine hydrochloride Raw materials Powder
Product Overview:
DL-carnitine hydrochloride is a mixed carnitine hydrochloride with the chemical formula C7H17ClNO3 and molecular weight of 198.667.It has been utilized to inhibit defects at the SnO2/calcite interface and to improve the efficiency of solar cells.
DL-Carnitine hydrochloride Raw materials Powder Attributes
CAS:461-05-2
MF:C7H16ClNO3
MW:197.66
EINECS:207-309-1
Specification: 99% min DL-Carnitine hydrochloride Powder
Sample:DL-Carnitine hydrochloride Powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance:White
Storage: Store at -20°C
Shelf Life: 2 Years
Test Method: HPLC
DL-Carnitine hydrochloride Raw materials Powder Details
DL-Carnitine hydrochloride Powder Usage and Synthesis.
DL-carnitine hydrochloride is an important feed additive with a variety of applications. It can be used as a carrier for process design, process scale-up and optimization, confirmation of chemical structure or components, quality and stability studies, impurity studies and other services for key intermediates of new drugs during the clinical trial stage and marketing application process of new drugs.
In addition, DL-carnitine hydrochloride can also be used as feed additives to improve the growth performance of animals, increase feed utilization, enhance the immunity of animals, and extend the production cycle of animals.
Uses of DL-Carnitine hydrochloride.
DL-carnitine hydrochloride is a chemical with the molecular formula C7H17ClNO3 and molecular weight 198.6672.It is often used as a nutritional supplement to help the body convert fat into energy. In addition, DL-Carnitine HCL has the following effects:
1) Inhibit the density of defective states at the SnO2/calcitonite interface;
2) Generation of DL-dimer through intermolecular esterification reaction, in which Cl- can passivate oxygen vacancies (VO) and N can coordinate with Sn4+ to passivate Sn-related defects;
3) Passivation of FA+ defects via hydrogen bonding and better passivation of Pb-related defects than DL monomer.
Pharmacological effect of DL-Carnitine hydrochloride.
Product Method of Bulk DL-Carnitine hydrochloride Powder.